Literature DB >> 22608479

Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study.

Maja G Erke1, Geir Bertelsen, Tunde Peto, Anne K Sjølie, Haakon Lindekleiv, Inger Njølstad.   

Abstract

PURPOSE: To describe the sex- and age-specific prevalence of drusen, geographic atrophy, and neovascular age-related macular degeneration (AMD).
DESIGN: Population-based, cross-sectional study. PARTICIPANTS: Caucasian adults aged 65 to 87 years from the 6th Tromsø Study, a population-based study conducted in 2007-2008 in the municipality of Tromsø, Norway.
METHODS: Digital color fundus photographs were graded for predominant phenotype based on drusen size, geographic atrophy, and neovascular AMD. MAIN OUTCOME MEASURES: Age-related macular degeneration.
RESULTS: A total of 3025 subjects participated; 89% of those were invited to the eye examinations. Gradable photographs were available for 2631 persons (mean age 72.3 years). Drusen 63-125 μm as the predominant phenotype were found in 34.9% of participants (95% confidence interval [CI], 33.1-36.8), drusen >125 μm were found in 24.1% (95% CI, 22.5-25.8), geographic atrophy was found in 1.0% of participants (95% CI, 0.6-1.4), and neovascular AMD was found in 2.5% of participants (95% CI, 1.9-3.1). Bilateral involvement of late AMD was present in 1.1% of the sample. Eyes with late AMD had a significantly lower refractive error (spherical equivalent 0.078 vs. 0.99 diopters, P<0.0001), and 42.5% of eyes had Snellen visual acuity ≤ 0.32.
CONCLUSIONS: The prevalence of AMD among the elderly persons in this study was similar to rates in other Caucasian populations. Late AMD was present in 10.9% of subjects aged 80 years or more. No sex differences in prevalence rates of large drusen or late AMD were observed. Lower refractive error was observed in eyes with late AMD than in eyes without late AMD.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22608479     DOI: 10.1016/j.ophtha.2012.03.016

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

Review 1.  Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy.

Authors:  Joon-Bom Kim; Eleonora M Lad
Journal:  Drugs Aging       Date:  2020-12-23       Impact factor: 3.923

2.  Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study.

Authors:  Christina A Korb; Ulrike B Kottler; Christian Wolfram; René Hoehn; Andreas Schulz; Isabella Zwiener; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

Review 3.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

4.  The prevalence and risk factors for age-related macular degeneration in rural-urban India, Sankara Nethralaya Rural-Urban Age-related Macular degeneration study, Report No. 1.

Authors:  R Raman; S S Pal; S Ganesan; L Gella; K Vaitheeswaran; T Sharma
Journal:  Eye (Lond)       Date:  2016-02-26       Impact factor: 3.775

5.  Modifiable Determinants of Satisfaction with Intravitreal Treatment in Patients with Neovascular Age-Related Macular Degeneration.

Authors:  Paola S Calles-Monar; María R Sanabria; Ana M Alonso-Tarancon; Rosa M Coco-Martin; Agustín Mayo-Iscar
Journal:  Drugs Aging       Date:  2022-04-29       Impact factor: 3.923

6.  Drusen and photoreceptor abnormalities in African-Americans with intermediate non-neovascular age-related macular degeneration.

Authors:  Sam Sadigh; Xunda Luo; Artur V Cideciyan; Alexander Sumaroka; Stacy L Boxley; Laura M Hall; Rebecca Sheplock; William J Feuer; Dwight S Stambolian; Samuel G Jacobson
Journal:  Curr Eye Res       Date:  2014-06-09       Impact factor: 2.424

7.  Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study.

Authors:  E J-C Huang; S-H Wu; C-H Lai; C-N Kuo; P-L Wu; C-L Chen; C-Y Chen; Y-C King; P-C Wu
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

8.  Cognitive function, drusen, and age-related macular degeneration: a cross-sectional study.

Authors:  H Lindekleiv; M G Erke; G Bertelsen; T Peto; K A Arntzen; H Schirmer; T Wilsgaard; E B Mathiesen; I Njølstad
Journal:  Eye (Lond)       Date:  2013-08-23       Impact factor: 3.775

9.  Prevalence of age-related macular degeneration among optometric telemedicine users in Spain: a retrospective nationwide population-based study.

Authors:  Miguel A Zapata; Anniken Burés; Roberto Gallego-Pinazo; Estanislao Gutiérrez-Sánchez; Andrea Oléñik; Salvador Pastor; Jorge Ruiz-Medrano; Cecilia Salinas; Susana Otero-Romero; Maximino Abraldes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-12       Impact factor: 3.117

10.  Prevalence of age-related macular degeneration among the elderly.

Authors:  Seyed Ahmad Rasoulinejad; Amin Zarghami; Seyed Reza Hosseini; Neda Rajaee; Seyed Elahe Rasoulinejad; Ebrahim Mikaniki
Journal:  Caspian J Intern Med       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.